1 enrolling by invitation. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Enrolling by invitation 1 |
Follow Val Lowe: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias C-11 ER-176, Blood Test - Lewy Body Dementia (LBD), Alzheimer Dementia (AD) | Phase 2 | Enrolling by invitation | Val Lowe | 125 | 2021-03-30 | 2026-05-22 |
Alzheimer Disease (1) · Lewy Body Disease (1) · Neuroinflammatory Diseases (1)
United States (1)